AIRNA
PrivateLast Round
Series B
Apr 1, 2025
Total Funding Raised
$305M
Company Overview
AIRNA is a biotechnology company that develops RNA-editing therapeutics to treat rare and common diseases by leveraging its proprietary RESTORE+™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIRNA Comparables
Compare AIRNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frequency Therapeutics | 91% | |
| Wave Life Sciences | 87% | |
| Ascidian Therapeutics | 81% |
AIRNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 1, 2025 | ||||
| Series A Extension | Jul 31, 2024 | ||||
| Series A | Sep 19, 2023 |
AIRNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeLink Ventures | Series B |
| Codon Capital | Series A |
| Forbion | Series B, Series A, Series A Extension |
| ARCH Venture Partners | Series B, Series A Extension, Series A |
| +ND Capital | Series B, Series A, Series A Extension |
| ARCH Venture Partners | Series B, Series A Extension, Series A |
| Alexandria Venture Investments | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 82% MoM.
- Apr 22, 2026
Developing new medicines for rare and common diseases, starting with AATD.
AIRNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AIRNA's valuation, stock price, and market status.
Is AIRNA a public or private company?
AIRNA is a private company.
What is the current stock price of AIRNA?
AIRNA is a private company with no public stock price. No recent secondary market data is available.
How much is AIRNA worth (valuation)?
Valuation information for AIRNA is not publicly available.
Can I buy AIRNA stock?
AIRNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AIRNA's last funding round?
AIRNA's most recent funding round was Series B on April 1, 2025.
Who are the main investors in AIRNA?
Key investors in AIRNA include ARCH Venture Partners, Venrock.
Will AIRNA IPO soon?
No public IPO plans have been announced for AIRNA.
How can I track AIRNA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AIRNA's secondary market activity and sign up for updates.